C12N 2730/00041
Use of virus, viral particle or viral elements as a vector
C12N2730/00041 (Use of virus, viral particle or viral elements as a vector) appears on 6 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 10
- Assignees
- 8
- Inventors
- 21
- Latest grant
- 16 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 2 |
| 2018 | 0 | 2 |
| 2019 | 2 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 2 |
By publication year.
Subgroups
Granted patents
- C12N 2730/00043Viral genome or elements thereof as genetic vectorIndexing code5
- C12N 2730/00042Virus or viral particle as vehicleIndexing code0
- C12N 2730/00044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2730/00045Special targeting system for viral vectorsIndexing code0
Recent patents
- Regulatory elements from lamium leaf distortion associated virus (LLDAV)16 Apr 2024US 11,959,085 B2Corteva Agriscience LLC
- Plant regulatory elements and methods of use thereof14 Jul 2020US 10,711,277 B2E. I. Du Pont de Nemours and Company
- Method for regenerating T cells and applications thereof17 Dec 2019US 10,508,287 B2Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
- Chimeric and proline rich protein promoters for expression in plants12 Mar 2019US 10,227,599 B2Monsanto Technology LLC
- Chimeric and proline rich protein promoters for expression in plants13 Sep 2016US 9,441,231 B2Monsanto Technology LLC
- Method for the generation of genetically modified NK cells19 Dec 2024US 2024/0415885 A1Miltenyi Biotec GmbH
- Regulatory Elements From Lamium Leaf Distortion Associated Virus (LLDAV)1 Aug 2024US 2024/0254498 A1Corteva Agriscience LLC
- Plant regulatory elements and methods of use thereof11 Jun 2020US 2020/0181630 A1E. I. Du Pont de Nemours and Company
- A method for regenerating t cells and applications thereof20 Dec 2018US 2018/0363007 A1Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
- Plant regulatory elements and methods of use thereof21 Jun 2018US 2018/0171348 A1E. I. Du Pont de Nemours and Company
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.